These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6214916)

  • 1. Captopril in the treatment of hypertension.
    Staessen J; Fagard R; Lijnen P; Amery A
    Acta Clin Belg; 1982; 37(3):164-84. PubMed ID: 6214916
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute effects of captopril on cardiopulmonary hemodynamics and renin-angiotensin-aldosterone and bradykinin profile in hypertension.
    Mookherjee S; Anderson GH; Eich R; Hill N; Smulyan H; Streeten DH; Vardan S; Warner R
    Am Heart J; 1983 Jan; 105(1):106-12. PubMed ID: 6336874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug therapy. Captopril.
    Vidt DG; Bravo EL; Fouad FM
    N Engl J Med; 1982 Jan; 306(4):214-9. PubMed ID: 7033784
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of captopril on the renin-angiotensin system in hypertensive children.
    Friedman AL; Chesney RW
    J Pediatr; 1983 Nov; 103(5):806-10. PubMed ID: 6355422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Captopril in the long-term treatment of essential hypertension: changes in the renin-angiotensin-aldosterone system.
    Riegger GA; Steilner H; Hayduk K; Liebau G
    Am J Cardiol; 1982 Apr; 49(6):1555-7. PubMed ID: 6803566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Captopril.
    Ram CV
    Arch Intern Med; 1982 May; 142(5):914-6. PubMed ID: 6282230
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antihypertensive, hemodynamic and endocrine effects of Captopril in arterial hypertension].
    Valvo E; Previato G; Oldrizzi L; Corgnati A; Lupo A; Loschiavo C; Tessitore N; Maschio G
    Minerva Nefrol; 1981; 28(2):139-41. PubMed ID: 7027091
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of angiotensin converting enzyme inhibitor (SQ 14225) on renin-angiotesin sytem and haemodynamics (author's transl)].
    Shigetomi S
    Horumon To Rinsho; 1980; 28(5):531-5. PubMed ID: 6248275
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of antihypertensive and hormonal effects of captopril and propranolol at rest and during exercise.
    Pickering TG; Case DB; Sullivan PA; Laragh JH
    Am J Cardiol; 1982 Apr; 49(6):1566-8. PubMed ID: 7041599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of the antihypertensive action of captopril.
    Mann JF
    Contrib Nephrol; 1984; 43():171-81. PubMed ID: 6386325
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of captopril in arterial hypertension with a stable and malignant course].
    Lordkipanidze NL
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(1):111-7. PubMed ID: 6145432
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension.
    Aldigier JC; Plouin PF; Guyene TT; Thibonnier M; Corvol P; Menard J
    Am J Cardiol; 1982 Apr; 49(6):1447-52. PubMed ID: 7041584
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure.
    Packer M; Lee WH; Medina N; Yushak M
    J Am Coll Cardiol; 1985 Sep; 6(3):635-45. PubMed ID: 2993397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Converting-enzyme inhibition for severe chronic heart failure: views from a skeptic.
    Packer M
    Int J Cardiol; 1985 Feb; 7(2):111-20. PubMed ID: 2982750
    [No Abstract]   [Full Text] [Related]  

  • 16. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
    Weber MA; Drayer JI; Priest RT; Chen TC
    Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril.
    Hollenberg NK
    Am J Med; 1984 May; 76(5B):22-8. PubMed ID: 6328983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension.
    Muiesan G; Alicandri CL; Agabiti-Rosei E; Fariello R; Beschi M; Boni E; Castellano M; Moniti E; Muiesan L; Romanelli G; Zanielli A
    Am J Cardiol; 1982 Apr; 49(6):1420-4. PubMed ID: 6280474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure.
    Atkinson AB; Cumming AM; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI
    Br J Clin Pharmacol; 1982 Jun; 13(6):855-8. PubMed ID: 7046776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive and renal effects of captopril in relation to renin activity and bradykinin-induced vasodilation.
    Kiowski W; van Brummelen P; Hulthén L; Amann FW; Bühler FR
    Clin Pharmacol Ther; 1982 Jun; 31(6):677-84. PubMed ID: 7042175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.